Pore Nabendu, Jiang Zibin, Shu Hui-Kuo, Bernhard Eric, Kao Gary D, Maity Amit
Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
Mol Cancer Res. 2006 Jul;4(7):471-9. doi: 10.1158/1541-7786.MCR-05-0234.
The phosphoinositide 3-kinase (PI3K)/Akt pathway is commonly activated in cancer; therefore, we investigated its role in hypoxia-inducible factor-1alpha (HIF-1alpha) regulation. Inhibition of PI3K in U87MG glioblastoma cells, which have activated PI3K/Akt activity secondary to phosphatase and tensin homologue deleted on chromosome 10 (PTEN) mutation, with LY294002 blunted the induction of HIF-1alpha protein and its targets vascular endothelial growth factor and glut1 mRNA in response to hypoxia. Introduction of wild-type PTEN into these cells also blunted HIF-1alpha induction in response to hypoxia and decreased HIF-1alpha accumulation in the presence of the proteasomal inhibitor MG132. Akt small interfering RNA (siRNA) also decreased HIF-1alpha induction under hypoxia and its accumulation in normoxia in the presence of dimethyloxallyl glycine, a prolyl hydroxylase inhibitor that prevents HIF-1alpha degradation. Metabolic labeling studies showed that Akt siRNA decreased HIF-1alpha translation in normoxia in the presence of dimethyloxallyl glycine and in hypoxia. Inhibition of mammalian target of rapamycin (mTOR) with rapamycin (10-100 nmol/L) had no significant effect on HIF-1alpha induction in a variety of cell lines, a finding that was confirmed using mTOR siRNA. Furthermore, neither mTOR siRNA nor rapamycin decreased HIF-1alpha translation as determined by metabolic labeling studies. Therefore, our results indicate that Akt can augment HIF-1alpha expression by increasing its translation under both normoxic and hypoxic conditions; however, the pathway we are investigating seems to be rapamycin insensitive and mTOR independent. These observations, which were made on cells grown in standard tissue culture medium (10% serum), were confirmed in PC3 prostate carcinoma cells. We did find that rapamycin could decrease HIF-1alpha expression when cells were cultured in low serum, but this seems to represent a different pathway.
磷酸肌醇3激酶(PI3K)/Akt信号通路在癌症中通常被激活;因此,我们研究了其在缺氧诱导因子-1α(HIF-1α)调控中的作用。在U87MG胶质母细胞瘤细胞中,由于第10号染色体上的磷酸酶和张力蛋白同源物缺失(PTEN)突变,PI3K/Akt活性被激活,用LY294002抑制PI3K可减弱缺氧诱导的HIF-1α蛋白及其靶标血管内皮生长因子和glut1 mRNA的诱导。将野生型PTEN导入这些细胞也可减弱缺氧诱导的HIF-1α诱导,并在蛋白酶体抑制剂MG132存在的情况下减少HIF-1α的积累。Akt小干扰RNA(siRNA)也可降低缺氧条件下HIF-1α的诱导及其在常氧条件下在二甲基草酰甘氨酸(一种脯氨酰羟化酶抑制剂,可防止HIF-1α降解)存在时的积累。代谢标记研究表明,Akt siRNA在二甲基草酰甘氨酸存在的常氧条件下以及缺氧条件下均可降低HIF-1α的翻译。用雷帕霉素(10 - 100 nmol/L)抑制哺乳动物雷帕霉素靶蛋白(mTOR)对多种细胞系中HIF-1α的诱导没有显著影响,这一发现通过mTOR siRNA得到证实。此外,可以通过代谢标记研究确定,mTOR siRNA和雷帕霉素均未降低HIF-1α的翻译。因此,我们的结果表明,Akt可通过在常氧和缺氧条件下增加其翻译来增强HIF-1α的表达;然而,我们正在研究的这条信号通路似乎对雷帕霉素不敏感且不依赖mTOR。这些在标准组织培养基(10%血清)中培养的细胞上所做的观察结果在PC3前列腺癌细胞中得到了证实。我们确实发现,当细胞在低血清中培养时,雷帕霉素可降低HIF-1α的表达,但这似乎代表了一条不同的信号通路。